Learn
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow...
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end...
New research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events in psychedelic clinical trials...
Psychedelic Twitter is a place for many interesting discussions, until you say "shrooms", and then swarms of plug bots arrive...
During a primetime interview with Fox Sports Sunday, the Packers QB credited ayahuasca with his recent MVP-caliber play...
In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers...
AI content creators like Stable Diffusion allow artists to create psychedelic music videos that will blow your mind. See for...
A recent paper claims we are living through a psychedelic hype bubble, but are the claims of miracle cures and...
If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep...
Personal growth doesn’t happen in a vacuum, it requires patience and a supportive community. Bonfire is here to give you...